Trial intelligence / Profile preview

2-Deoxyglucose in Advanced Cancer and Hormone Refractory Prostate Cancer

NCT00633087Phase 2Terminated

Sponsor
Rutgers University
Start
Nov 2006
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of 2-deoxy-d-glucose in solid tumor, prostate cancer (PCa), sponsored by Rutgers University. Started Nov 2006; status: terminated.

02

Drugs

2-deoxy-d-glucose
03

Conditions

solid tumorprostate cancer (PCa)

Beyond the preview

Go deeper on NCT00633087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00633087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call